Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in premature infants at high risk for Bronchopulmonary Dysplasia(BPD)
Epistemonikos ID: 3000d32196b78497c3876d016069a709109e9bfb
First added on: May 21, 2024